Results 141 to 150 of about 31,226 (229)

Rapid Fluid Resolution and Durability With Faricimab in Neovascular Age-Related Macular Degeneration.

JAMA Ophthalmol
Pitcher JD, Koh AHC, Tan CS, Vakharia P, Dagincourt N, Patel S, Yang M, Margaron P, Gallego-Pinazo R.   +8 more
europepmc   +1 more source

Comparison of Short-term Outcomes Between Faricimab and High-Dose Aflibercept in Patients With Neovascular Age-related Macular Degeneration. [PDF]

J Vitreoretin Dis
Shiratori M, Maruyama-Inoue M, Yanagi Y, Inoue T, Kadonosono K.   +4 more
europepmc   +1 more source

Efficacy of Faricimab in Neovascular Age-Related Macular Degeneration: A Single-Arm Systematic Review and Meta-Analysis. [PDF]

Ophthalmic Res
Karam M, Baeshen M, Alfuzaie R, Mohammad M, Alshatti A, Samet A, Paez-Escamilla M, Sun V.   +7 more
europepmc   +1 more source

Short term real-world effectiveness of faricimab in neovascular age-related macular degeneration patients in the Republic of Korea. [PDF]

Sci Rep
Chung DH, Jee D, Roh YJ, Ra H, Lee MY, Won JY, Shin JA, Jung SH, Park YH.   +8 more
europepmc   +1 more source

Long-Term Follow-Up of Faricimab Intravitreal Injections in Naïve Neovascular Age-Related Macular Degeneration.

Ophthalmic Res
Belloni Baroni L, Toto L, Formenti F, Passamonti M, Quarta A, Ruggeri ML, Aloia R, Di Nicola M, Mastropasqua R.   +8 more
europepmc   +1 more source

Therapeutic Equivalence of Eyluxvi (Aflibercept) to Eylea in Neovascular Age-Related Macular Degeneration: ALTERA Trial (Randomized). [PDF]

Ophthalmol Ther
Raczynska D, Ernest J, Baumane K, Sagong M, Akiyama K, Rauschning W, Vajas A, Nowosielska A, Dusova J, Majtánová N, Oleksy P, Kuneva I, Resch M, Lange N, Briede E, Bajdik B, Jeong A, Kozub B, Papp A.   +18 more
europepmc   +1 more source

Real-world treatment outcomes of aflibercept versus bevacizumab for neovascular age-related macular degeneration. [PDF]

Graefes Arch Clin Exp Ophthalmol
Mhmud H, Vermeulen JP, Adanc B, Klevering JBJ, Groenink-Lindenhovius C, Tigchelaar OAM, Ponsioen TL, Klaver CCW, Witmer AN.   +8 more
europepmc   +1 more source

Integrating genetics, age and imaging to predict treatment outcomes in neovascular age-related macular degeneration: a proof-of-concept study. [PDF]

Sci Rep
Moghul I, Pontikos N, Sharma A, Liu T, Soomro T, Wagner SK, Silva AS, Zhang G, Naik G, Bagga P, Chan YW, Keane PA, Cipriani V, Sivaprasad S, Webster AR, Balaskas K.   +15 more
europepmc   +1 more source

Intestinal Microbiome of Newly Diagnosed Patients With Neovascular Age-Related Macular Degeneration: A 16S rRNA Gene Sequencing Study. [PDF]

Cureus
Katsanos A, Benekos K, Karavasili M, Gorgoli K, Kostoulas C, Gartzonika K, Christodoulou DK, Katsanos K, Georgiou I.   +8 more
europepmc   +1 more source

Initial Experiences of Switching to Aflibercept 8 mg for Neovascular Age-Related Macular Degeneration and Polypoidal Chorodal Vasculopathy in an Asian Population. [PDF]

Ophthalmol Ther
Cheung CMG, Kikushima W, Teo KYC.
europepmc   +1 more source